Advertisement
Advertisement

LSTA

LSTA logo

Lisata Therapeutics, Inc. Common Stock

3.15
USD
Sponsored
-0.08
-2.48%
May 08, 15:30 UTC -4
Closed
exchange

After-Market

3.17

+0.02
+0.79%

Lisata Therapeutics, Inc. Common Stock Profile

About

Lisata Therapeutics Inc. is a clinical-stage biopharmaceutical company. It involved in discovery, development and commercialization of therapies for the treatment of advanced solid tumors and other major diseases. The company's principal product candidate includes LSTA1. Lisata Therapeutics Inc., formerly known as Caladrius Biosciences Inc., is based in BASKING RIDGE, N.J.

Info & Links

CEO

David J. Mazzo

Headquarters

110 ALLEN ROAD, SECOND FLOOR
BASKING RIDGE, NJ 07920, UNITED STATES

Industry

Medical Biomedical And Genetics

Sector

Medical

Website

www.lisata.com

Auditor

GRANT THORNTON LLP

Share holders

322

Employees

21

Lisata Therapeutics, Inc. Common Stock Statistics

Valuation Measures

Market Capitalization2

28.91M

Enterprise Value

12.96M

Enterprise Value/EBITDA(ttm)

-0.71

Price to Earnings Ratio(ttm)

--

Price to Sales(ttm)

--

Price to Book(mrq)

3.02

Price to Cash(ytd)

--

Profitability

Gross Margin(ttm)

50.00%

Operating Margin(ttm)

--

Profit Margin(ttm)

-2402.43%

Return on Equity(ttm)

-85.50%

Return on Invested Capital(ttm)

-86.30%

Return on Assets(ttm)

-70.85%

Income Statement

Revenue(ttm)

170.00K

Revenue Per Share(ttm)

0.02

Gross Profit(ttm)

170.00K

EBITDA(ttm)3

-18.14M

Net Income Available to Common(ttm)

-16.59M

Diluted EPS(ttm)

-1.91

Share Statistics

Beta (5Y Monthly)

1.10

52-Week Change

32.64%

S&P 500 52-Week Change

26.60%

S&P 500 Member

Yes

Stock Optionable

Yes

Total Shares Outstanding1

9.03M

Dividend Yield

0.00%

Float4

8.16M

% Held by Insiders

9.60%

% Held by Institutions

8.94%

Balance Sheet

Total Cash(mrq)

15.96M

Total Cash Per Share(mrq)

1.77

Total Debt(mrq)

0.00

Total Debt/Equity(mrq)

0.00%

Current Ratio(mrq)

5.76%

Quick Ratio(mrq)

5.76%

Book Value Per Share(mrq)

1.65

Cash Flow

Operating Cash Flow Per Share(ytd)

-1.84

Free Cash Flow(ytd)

-15.98M

Table Key

mrq = Most Recent Quarter

ttm = Trailing Twelve Months

ytd = Year To Date

Footnotes

Data provided by Zacks Investment Research or calculated by FXEmpire. All numbers are rounded to the closest decimal.

  • 1 Total Shares outstanding is taken from the most recently filed quarterly or annual report.
  • 2 Market Cap is calculated using total shares outstanding and the most recent share price.
  • 3 EBITDA is calculated using methodology that may differ from that used by a company in its reporting.
  • 4 The float is a measure of the number of shares available for trading by the public. It's calculated by taking the number of issued and outstanding shares minus any restricted stock, which might not be publicly traded.
Advertisement